Lataa...
Intralesional Meglumine Antimoniate for Treatment of Cutaneous Leishmaniasis Patients with Contraindication to Systemic Therapy from Rio de Janeiro (2000 to 2006)
We evaluated the effectiveness and safety of intralesional meglumine antimoniate (MA) in 24 not submitted to previous treatment patients with cutaneous leishmaniasis (CL) and with contraindication to systemic therapy. Each treatment consisted of one to four intralesional applications of MA at 15-day...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society of Tropical Medicine and Hygiene
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3414560/ https://ncbi.nlm.nih.gov/pubmed/22855754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2012.11-0612 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|